Evicenter
MarkdownMedical informationP&T meetings
Inaxaplin (VX-147)

APOL1-mediated kidney disease

Launch
Not announced
Last updated
162 sources

Product information and disease descriptionProduct descriptionProduct information

Dosage forms and strengths

4 evidence topics · 5 sources

Commercial strengths and package sizes

No evidence found.